Eberlein elected chairman of National Comprehensive Cancer Network board
Network is alliance of 27 leading cancer centers devoted to patient care, research, education
Eberlein
Timothy J. Eberlein, MD, director of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, has been elected chairman of the National Comprehensive Cancer Network (NCCN) board of directors.
The NCCN is a not-for-profit alliance of 27 leading U.S. cancer centers devoted to patient care, research and education. Siteman is the only NCCN member institution in Missouri.
“I am honored to be elected to lead such a prestigious organization devoted to the discovery and delivery of better therapies for people with cancer,” said Eberlein, who also is the Bixby Professor of Surgery and head of the Department of Surgery at the School of Medicine.
Eberlein, a breast surgeon, had served as the NCCN vice chairman since 2013. He was elected chairman during the NCCN’s 21st Annual Conference, March 31-April 2 in Hollywood, Fla. He succeeds Samuel M. Silver, MD, PhD, of the University of Michigan Comprehensive Cancer Center.
The NCCN board of directors is comprised of two representatives from each of the network’s 27 member institutions. Siteman’s other board member is Trisha Lollo, vice president of cancer services at Barnes-Jewish Hospital.
Eberlein has held leadership roles on a number of NCCN committees, including the Executive Committee; the Governance Committee, for which he served as chairman; and the NCCN Guidelines Steering Committee. In addition, he has held numerous positions in the fields of cancer and surgery and is a member of the National Academy of Medicine.
